IP Verse

Chemically Modified Guide Rnas For Crispr/Cas-Mediated Gene Regulation

Patent No. EP3280803 (titled "Chemically Modified Guide Rnas For Crispr/Cas-Mediated Gene Regulation") was filed by Agilent on Apr 5, 2016. The application was issued on May 26, 2021.

Patent Summary

Patent Family

Patent Family

Patent Oppositions (3)

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentative
MAIWALDFeb 28, 2022MAIWALD
JAMES POOLEAug 9, 2021CARPMAELS & RANSFORD
WUESTHOFF & WUESTHOFF PATENTANWALTE PARTG MBBJul 28, 2021WICHMANN

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents

EP3280803

AGILENT
Application Number
EP16720220A
Filing Date
Apr 5, 2016
Status
Granted And Under Opposition
Apr 23, 2021
Publication Date
May 26, 2021
External Links
Slate, Register , Google Patents